window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • European biotech,Immunology,Movers & Shakers,Research & Development

    Nucleome Therapeutics appoints Michelle Morrow as chief scientific officer

    Nucleome Therapeutics has appointed Michelle Morrow as chief scientific officer, [...]

    February 16, 2026
  • Central Nervous System,Clinical Development,Clinical Trials,Drug Development,FDA,Pharmaceuticals and therapeutics,Precision medicine,Research & Development

    Alto Neuroscience completes Phase 2 enrollment for ALTO-101 in cognitive impairment associated with schizophrenia

    Alto Neuroscience has completed patient enrollment in its Phase 2 [...]

    February 13, 2026
  • Biologics & Biosimilars,Biotech,Clinical Development,Clinical Trials,Drug Development,Pharmaceuticals and therapeutics,Research & Development

    Evogene and Shanghai Lishan Biopharmaceuticals enter exclusive licensing agreement for BMC128

    Evogene Ltd and Shanghai Lishan Biopharmaceuticals Co. have entered into [...]

    February 13, 2026
  • Clinical Development,Drug Delivery & Formulation,Drug Development,Pharmaceuticals and therapeutics,Research & Development

    AmacaThera named Life Sciences Ontario emerging company of the year

    AmacaThera has been named Emerging Company of the Year by [...]

    February 13, 2026
  • Clinical Development,Drug Development,European biotech,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery

    Syngene International has entered a collaboration with Johns Hopkins University [...]

    February 12, 2026
  • Biotech,Drug Development,Oncology,Research & Development,Technology and platforms

    SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research

    SPT Labtech and BellBrook Labs have introduced a miniaturised high-throughput [...]

    February 11, 2026
  • Biotech,Global health,Immunology,Pharmaceuticals and therapeutics,Research & Development

    BNPP AM Alts invests $115M in ILiAD Biotechnologies to advance whooping cough vaccine

    BNP Paribas Asset Management Alts (BNPP AM Alts) has made [...]

    February 11, 2026
  • Infectious Diseases,Research & Development,RNA Therapeutics

    Circio and University of Texas Medical Branch partner on infectious disease research using circular RNA

    Circio has entered a research collaboration with the University of [...]

    February 9, 2026
  • Cell & Gene Therapy,Genetic Diseases,Research & Development,RNA Therapeutics

    SynGenSys launches Liver.SET library for liver-specific gene expression in in vivo therapies

    SynGenSys has launched Liver.SET, a library of liver-specific synthetic promoters [...]

    February 5, 2026
  • Cardiovascular diseases,Clinical Trials,Rare Diseases,Research & Development

    Cereno Scientific completes expanded access program milestone for CS1 in pulmonary arterial hypertension

    Cereno Scientific has completed the last patient’s last visit in [...]

    February 4, 2026
Previous678Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board
    Categories: Artificial Intelligence, Biotech, Drug Development, Drug discovery, Research & Development
  • Weite Oldenziel
    Ofichem unifies CDMO and pharmaceutical supply brands under single identity
    Categories: CDMOs & Manufacturing, Supply Chain & Logistics
  • DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development
    Categories: Artificial Intelligence, Drug discovery, Funding, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top